Endometrial Cancer
Copyright policy )Endometrial Cancer
Despite the questions and barriers, the incorporation of molecular therapy into treatment regimens in endometrial cancer is an exciting area of investigation with the potential to improve outcomes. Outside of the development of a reliable screening test for endometrial cancer, converting the disease to a chronic state and improving progression-free survival is our best hope to reverse the concerning trend of decreasing 5-year survival for this disease.
- University of Iowa United States
Middle Aged, Hysterectomy, Prognosis, United States, Endometrial Neoplasms, Postmenopause, Chemotherapy, Adjuvant, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Humans, Lymph Node Excision, Female, Molecular Targeted Therapy, Obesity, Uterine Hemorrhage, Aged
Middle Aged, Hysterectomy, Prognosis, United States, Endometrial Neoplasms, Postmenopause, Chemotherapy, Adjuvant, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Humans, Lymph Node Excision, Female, Molecular Targeted Therapy, Obesity, Uterine Hemorrhage, Aged
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).56 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!